Lakewood-Amedex
is a clinical-stage pharmaceutical company that develops antimicrobial therapeutics for the treatment of infectious diseases... Read moreLakewood-Amedex
is a clinical-stage pharmaceutical company that develops antimicrobial therapeutics for the treatment of infectious diseases... Read more
News
Nov 01, 2023
PR Newswire
Press Release: Lakewood-Amedex : Lakewood-Amedex Announces Leadership Changes
Apr 05, 2022
FirstWord Pharma
Lakewood-Amedex: Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)
Jan 25, 2022
MarketScreener
Lakewood-Amedex: LAKEWOOD-AMEDEX APPOINTS TWO NEW BOARD MEMBERS
Jan 19, 2022
MarketScreener
Lakewood-Amedex: LAKEWOOD-AMEDEX APPOINTS CHIEF MEDICAL OFFICER AND ADDS NEW MANAGEMENT TEAM MEMBERS
Jan 05, 2021
SEC
Lakewood-Amedex: Lakewood-Amedex has Received $24.1M in Equity Funding
Jul 21, 2020
PR Newswire
Press Release: Lakewoodamedex : Lakewood-Amedex Therapeutics Announces the Election of Peter B. Corr, Ph.D., as Chairman of the Board of Directors
Jun 03, 2020
MarketScreener
Lakewoodamedex: Transparency Life Sciences : and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chronic Diabetic Foot Ulcers
Jan 20, 2019
PharmiWeb
Lakewoodamedex: Lakewood-Amedex Prepares To Launch A Phase 2 cDFU Clinical Trial for Its Nu-3 Antimicrobial In The Bahamas
Dec 01, 2018
PR-Inside
Press Release: Lakewoodamedex : Lakewood-Amedex to Present at the 11th Annual LD Micro Main Event
Sep 29, 2018
BioPortfolio
Lakewoodamedex: LakewoodAmedex Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
